GLP-1 (glucagon-like peptide-1) agonists are a class of medications used to treat type 2 diabetes by stimulating insulin release and decreasing glucagon secretion in response to elevated blood sugar levels
By mimicking the actions of these hormones, Zepbound effectively reduces the feeling of hunger and slows digestion
Pure Encapsulations SeroPlus Pure Encapsulations SeroPlus Serotonin helps regulate mood, anxiety, fear, and repetitive behaviors, and disruptions in serotonin pathways appear to contribute to OCD symptoms
These findings indicate that Retatrutide did not prevent diabetes-induced weight loss, as STZ and STZR showed comparable reductions
Some patients have reported feeling nauseous, while others have experienced constipation, cramping, headache, heartburn, and dizziness